Biocept, Inc. (BIOCQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 6, 2026, 9:30 AM EST
Biocept Revenue
Biocept had revenue of $589.00K in the quarter ending June 30, 2023, a decrease of -89.88%. This brings the company's revenue in the last twelve months to $1.36M, down -97.63% year-over-year. In the year 2022, Biocept had annual revenue of $25.86M, down -57.78%.
Revenue (ttm)
1.36M
Revenue Growth
-97.63%
P/S Ratio
0.00
Revenue / Employee
27.14K
Employees
50
Market Cap
263.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 25.86M | -35.39M | -57.78% |
| Dec 31, 2021 | 61.25M | 33.79M | 123.04% |
| Dec 31, 2020 | 27.46M | 21.93M | 396.71% |
| Dec 31, 2019 | 5.53M | 2.28M | 70.09% |
| Dec 31, 2018 | 3.25M | -1.82M | -35.87% |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HTG Molecular Diagnostics | 6.21M |
| Rosetta Genomics | 2.86M |
| Response Genetics | 16.62M |
| Arrayit | 2.82M |
| Cyclo3pss | 366.01K |
| Integrative Health Technologies | 447.50K |
| Optigenex | 991.25K |
| Medivolve | 666.14K |